jujuboside a has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, M; Liang, X; Liu, Q; Luo, R; Peng, X; Wang, X; Zhong, Y; Zhu, J | 1 |
| Cao, XY; Hao, SL; Ji, B; Jiang, ZZ; Kuang, XF; Li, L; Liu, YY; Lu, Q; Qian, ST; Wei, CJ; Xu, J; Yang, TT; Yin, XX; Yuan, JY | 1 |
2 other study(ies) available for jujuboside a and Diabetic Nephropathies
| Article | Year |
|---|---|
Jujuboside A ameliorates high fat diet and streptozotocin induced diabetic nephropathy via suppressing oxidative stress, apoptosis, and enhancing autophagy.
Topics: Animals; Apoptosis; Autophagy; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Kidney; Male; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Saponins; Streptozocin | 2022 |
Jujuboside A ameliorates tubulointerstitial fibrosis in diabetic mice through down-regulating the YY1/TGF-β1 signaling pathway.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Mice; Saponins; Signal Transduction; Streptozocin; Transforming Growth Factor beta1 | 2022 |